Wednesday
SESSION 39: MORE TOPICS RELATED TO TEVAR, THE THORACIC AORTA AND TREATMENT OF AORTIC DISSECTIONS
SESSION 39 SCHEDULE
6:54 AM - 6:59 AM Aortic Dissection Chronicity Is Patient Specific Not Time Determined: Need IVUS Or 4D MRI To Determine Flap Mobility And Plan Treatment
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
7:00 AM - 7:05 AM Update On The True Lumen/False Lumen Ratio As A Predictor Of Need For TEVAR Treatment With TBAD Patients
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
7:06 AM - 7:11 AM Strategies And Solutions When TEVAR Fails In Treating A TBAD
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
7:12 AM - 7:19 AM Experience With Carotid Subclavian Bypass To Revascularize The LSA With TEVAR: Technique, Complications And Outcomes
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
7:18 AM - 7:23 AM Although 30-Day Mortality For TEVAR For Elective And Ruptured Thoracic Aneurysms, And TBAD Is Good, Longer Term Survival Is Poor Especially For Ruptures
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
7:24 AM - 7:29 AM What Are The Expansion Rates Of Thoracic Aortic Aneurysms At Various Levels And At What Diameter Should They Be Fixed Because Of Increased Rupture Risk
  Presenter(s):John A. Elefteriades, MD  
  View Slides in PDF      
7:30 AM - 7:35 AM Influence Of Arterial Hypertension Or Hypotension On Aortic Diameter And How Should Blood Pressure Influence Diameter Sizing Of Endografts For TEVAR
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
7:36 AM - 7:41 AM What Does Volume Analysis Of True And False Lumens Tell Us After Standard And Petticoat (Composite) TEVAR For Acute TBADs
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
7:42 AM - 7:47 AM 5-Year Outcomes (Durability) Of TEVAR: For Thoracic Aortic Aneurysms: Data From The VALOR II Registry
  Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
  View Slides in PDF      
7:48 AM - 7:53 AM 30 Years Of Chinese Progress In Treating TBADs: What Has Happened In The Last 5 Years And What Challenges Remain
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
7:54 AM - 8:00 AM Panel Discussion
END OF SESSION 39
previous next